Provided by Tiger Trade Technology Pte. Ltd.

Standard BioTools Inc.

0.6485
-0.0302-4.45%
Volume:918.99K
Turnover:601.36K
Market Cap:254.59M
PE:2.95
High:0.6723
Open:0.6700
Low:0.6427
Close:0.6787
52wk High:1.72
52wk Low:0.6251
Shares:392.58M
Float Shares:185.00M
Volume Ratio:1.71
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2196
EPS(LYR):-0.1963
ROE:-11.18%
ROA:-6.61%
PB:0.47
PE(LYR):-3.30

Loading ...

Stocks to Watch: Standard BioTools, NeoGenomics, Pinterest

Dow Jones
·
Oct 06

Standard BioTools Announces Agreement to Sell Microfluidics Business to Archimed

THOMSON REUTERS
·
Oct 06

Standard BioTools - Deal Expected to Close in About 30 Days

THOMSON REUTERS
·
Oct 06

October 2026's Top Picks: Promising Penny Stocks

Simply Wall St.
·
Oct 06

Standard BioTools Switches Mass Cytometry Sale to Element Biosystems for $5.5 Million Cash

Reuters
·
Oct 01

Standard BioTools: Terminated Its Previously Announced Agreement to Sell Its Mass Cytometry Business to Multiplex Bio

THOMSON REUTERS
·
Oct 01

Standard BioTools Provides Update on Sale of Mass Cytometry Business

THOMSON REUTERS
·
Oct 01

Proacta and PZU Zdrowie Launch Pilot of Dbam o Siebie Smart LAB

TIPRANKS
·
Aug 27

Sheffield Green's subsidiary under investigation on alleged discrepancies of employment contracts

Teo Zheng Long
·
Aug 24

Standard BioTools Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Standard BioTools Q2 Revenue Falls on Consumables Weakness

Reuters
·
Aug 06

Standard BioTools Q2 FY26 Operating Loss Narrows 1% to $25.4 Million; Revenue Falls 7.6% to $20.1 Million

Reuters
·
Aug 06

Standard BioTools Q2 EPS USD -0.07

Reuters
·
Aug 06

Standard BioTools: Withdrawing Fy2026 REV Outlook Given Pending Merger with Treeline Biosciences

THOMSON REUTERS
·
Aug 06

Standard BioTools: Continued Cost Discipline Drove 84% Year-over-Year Improvement in Adj Ebitda for Q2

THOMSON REUTERS
·
Aug 06

Standard BioTools - Merger with Treeline Biosciences Expected to Close Before Year-End 2026

THOMSON REUTERS
·
Aug 06

Standard BioTools Inc. Expected to Post a Loss of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 04

Standard BioTools Amends 8-K to File Mass Cytometry Sale Agreement with Multiplex Bio

Reuters
·
Jul 29

Standard BioTools - Enters Termination, Waiver and Release Agreement with Illumina on July 24, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 28

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

THOMSON REUTERS
·
Jul 28